BET1L

Across TCGA pan-cancer cohorts, BET1L mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated BET1L data layer compared with 23 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher BET1L mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated BET1L expression acts as an unfavorable survival marker, although some lineages such as COAD and LUAD show a favorable association.

COAD, CCRCC, and LSCC are the cancer types where BET1L mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	1.000	0.888	.023	48	view →
CCRCC	OS	Median	II,III,IV	0.822	1.000	.006	32	view →
LSCC	DFS	Median	II,III,IV	0.495	0.889	<.001	16	view →
LUAD	OS	Median	III,IV	0.740	0.221	.001	15	view →
GBM	DFS	Quartile	All	0.627	0.907	.026	6	view →
PDAC	DFS	Quartile	All	0.202	0.412	.016	5	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

BET1L–COAD (DFS)

Open the COAD breakdown →